Literature DB >> 21863401

Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.

Ji Hoon Phi1, Kyu-Chang Wang, Sung-Hye Park, Il Han Kim, In-One Kim, Kyung Duk Park, Hyo Seop Ahn, Ji Yeoun Lee, Young-Je Son, Seung-Ki Kim.   

Abstract

Pediatric infratentorial ependymomas are difficult to cure. Despite the availability of advanced therapeutic modalities for brain tumors, total surgical resection remains the most important prognostic factor. Recently, histological grade emerged as an independent prognostic factor for intracranial ependymoma. We retrospectively reviewed the treatment outcome of 33 pediatric patients with infratentorial ependymoma. Progression-free survival (PFS) and overall survival (OS) rates were calculated and relevant prognostic factors were analyzed. Fourteen patients (42%) were under the age of 3 at diagnosis. Gross total resection was achieved in 16 patients (49%). Anaplastic histology was found in 13 patients (39%). Adjuvant therapies were delayed until progression in 12 patients (36%). Actuarial PFS rates were 64% in the first year and 29% in the fifth year. Actuarial OS rates were 91% in the first year and 71% in the fifth year. On univariate analysis, brainstem invasion (P = 0.047), anaplastic histology (P = 0.004), higher mitotic count (P = 0.001), and higher Ki-67 index (P = 0.004) were significantly related to a shorter PFS. Gross total resection (P = 0.029) and a greater age at diagnosis (P = 0.033) were significantly related to a longer PFS. On multivariate analysis, anaplastic histology alone was significantly related to a shorter PFS (P = 0.023). Gross total resection (P = 0.039) was significantly related to a longer overall survival (OS) on multivariate analysis. Anaplastic histology and gross total resection were the most important clinical factors affecting PFS and OS, respectively. Anaplastic histology, mitotic count, and Ki-67 index can be used as universal and easily available prognostic parameters in infratentorial ependymomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21863401     DOI: 10.1007/s11060-011-0699-x

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.

Authors:  Maura Massimino; Lorenza Gandola; Salvina Barra; Felice Giangaspero; Cecilia Casali; Paolo Potepan; Concezio Di Rocco; Paolo Nozza; Paola Collini; Elisabetta Viscardi; Daniele Bertin; Veronica Biassoni; Armando Cama; Claudia Milanaccio; Piergiorgio Modena; Rita Balter; Giampiero Tamburrini; Paola Peretta; Maurizio Mascarin; Giovanni Scarzello; Paola Fidani; Giuseppe Maria Milano; Iacopo Sardi; Lorenzo Genitori; Maria Luisa Garrè
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-18       Impact factor: 7.038

2.  Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

Authors:  Piergiorgio Modena; Elena Lualdi; Federica Facchinetti; Joris Veltman; James F Reid; Simone Minardi; Irene Janssen; Felice Giangaspero; Marco Forni; Gaetano Finocchiaro; Lorenzo Genitori; Flavio Giordano; Riccardo Riccardi; Eric F P M Schoenmakers; Maura Massimino; Gabriella Sozzi
Journal:  J Clin Oncol       Date:  2006-11-20       Impact factor: 44.544

3.  Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy.

Authors:  Marie-Lise C van Veelen-Vincent; Alain Pierre-Kahn; Chantale Kalifa; Christian Sainte-Rose; Michel Zerah; John Thorne; Dominique Renier
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

4.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

5.  Postoperative radiation therapy for grade II and III intracranial ependymoma.

Authors:  David B Mansur; Arie Perry; Veena Rajaram; Jeff M Michalski; T S Park; Jeffrey R Leonard; Lori Luchtman-Jones; Keith M Rich; Perry W Grigsby; Mary Ann Lockett; Sasha H Wahab; Joseph R Simpson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-02-01       Impact factor: 7.038

6.  Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.

Authors:  Frank Mendrzyk; Andrey Korshunov; Axel Benner; Grischa Toedt; Stefan Pfister; Bernhard Radlwimmer; Peter Lichter
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

7.  Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?

Authors:  Carole Ramirez; Clive Bowman; Claude-Alain Maurage; François Dubois; Serge Blond; Nicole Porchet; Fabienne Escande
Journal:  Neuro Oncol       Date:  2010-02-14       Impact factor: 12.300

8.  Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas.

Authors:  K Ikezaki; T Matsushima; T Inoue; N Yokoyama; Y Kaneko; M Fukui
Journal:  Neurosurgery       Date:  1993-01       Impact factor: 4.654

9.  Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.

Authors:  Shannon M MacDonald; Sairos Safai; Alexei Trofimov; John Wolfgang; Barbara Fullerton; Beow Y Yeap; Thomas Bortfeld; Nancy J Tarbell; Torunn Yock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-05       Impact factor: 7.038

10.  The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors.

Authors:  Tarik Tihan; Tianni Zhou; Emi Holmes; Peter C Burger; Sema Ozuysal; Elisabeth J Rushing
Journal:  Mod Pathol       Date:  2007-12-14       Impact factor: 7.842

View more
  9 in total

1.  Stereotactic radiosurgery for patients with recurrent intracranial ependymomas.

Authors:  Michael C Stauder; Nadia Ni Laack; Kamran A Ahmed; Michael J Link; Paula J Schomberg; Bruce E Pollock
Journal:  J Neurooncol       Date:  2012-03-23       Impact factor: 4.130

2.  Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients.

Authors:  Shannon M Macdonald; Roshan Sethi; Beverly Lavally; Beow Y Yeap; Karen J Marcus; Paul Caruso; Margaret Pulsifer; Mary Huang; David Ebb; Nancy J Tarbell; Torunn I Yock
Journal:  Neuro Oncol       Date:  2013-10-06       Impact factor: 12.300

3.  Pencil beam scanning proton therapy for pediatric intracranial ependymoma.

Authors:  Carmen Ares; Francesca Albertini; Martina Frei-Welte; Alessandra Bolsi; Michael A Grotzer; Gudrun Goitein; Damien C Weber
Journal:  J Neurooncol       Date:  2016-03-05       Impact factor: 4.130

4.  Retrospective analysis of treatment outcome of pediatric ependymomas in Korea: analysis of Korean multi-institutional data.

Authors:  Yeon-Joo Kim; Joo-Young Kim; Do Hoon Lim; Hyeon Jin Park; Jungnam Joo; Ki Woong Sung; Hyung Jin Shin; Seung-Ki Kim; Ji Hoon Phi; Il Han Kim; Kyung Duk Park; Seung-do Ahn; Jinhong Jung; Young-Shin Ra; Young Sin Rha; Dong-Seok Kim; Chang-Ok Suh
Journal:  J Neurooncol       Date:  2013-03-06       Impact factor: 4.130

5.  Infratentorial ependymomas--a study of the centre in Katowice.

Authors:  Marek Mandera; Joanna Makarska; Grażyna Sobol; Katarzyna Musioł
Journal:  Childs Nerv Syst       Date:  2015-03-31       Impact factor: 1.475

6.  Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.

Authors:  József Virág; Christine Haberler; Gábor Baksa; Violetta Piurkó; Zita Hegedüs; Lilla Reiniger; Katalin Bálint; Monika Chocholous; András Kiss; Gábor Lotz; Tibor Glasz; Zsuzsa Schaff; Miklós Garami; Balázs Hegedűs
Journal:  Pathol Oncol Res       Date:  2016-07-09       Impact factor: 3.201

7.  A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma.

Authors:  Durgagauri H Sabnis; Lisa C D Storer; Jo-Fen Liu; Hannah K Jackson; J P Kilday; Richard G Grundy; Ian D Kerr; Beth Coyle
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

8.  Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling.

Authors:  Ji Hoon Phi; Seung-Ah Choi; Seung-Ki Kim; Kyu-Chang Wang; Ji Yeoun Lee; Dong Gyu Kim
Journal:  Transl Oncol       Date:  2015-10       Impact factor: 4.243

9.  Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas.

Authors:  Muh-Lii Liang; Tsung-Han Hsieh; Yun-Ru Liu; Yi-Wei Chen; Yi-Yen Lee; Feng-Chi Chang; Shih-Chieh Lin; Ming-Chao Huang; Ho Donald Ming-Tak; Tai-Tong Wong; Yun Yen; Muh-Hwa Yang
Journal:  Oncotarget       Date:  2017-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.